Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neurotransmission

Details for Australian Patent Application No. 2006218012 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Chollet, Marylene; Feenstra, Roelof W.; Drukarch, Benjamin; Tulp, Martinus; Iwema Bakker, Wouter I.; Van Vliet, Bernard J.; Schoffelmeer, Anton N. M.; Christen, Marie-Odile; Burgot, JeanLouise

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006218012

PCT Pub. Number WO2006/089861

Priority 05101405.8 24.02.05 EP; 60/655,428 24.02.05 US

Filing date 17 February 2006

Wipo publication date 31 August 2006

International Classifications

C07D 339/04 (2006.01) Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms

A61K 31/385 (2006.01) - having two or more sulfur atoms in the same ring

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/089861 Priority application(s): WO2006/089861

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218020-Pharmaceutical combination of Bcr-Abl and RAF inhibitors

2006218010-Novel drugs for treating respiratory diseases